Annual EBIT
-$44.55 M
-$18.08 M-68.30%
31 December 2023
Summary:
Zevra Therapeutics annual earnings before interest & taxes is currently -$44.55 million, with the most recent change of -$18.08 million (-68.30%) on 31 December 2023. During the last 3 years, it has fallen by -$38.84 million (-681.00%). ZVRA annual EBIT is now -1162.34% below its all-time high of -$3.46 million.ZVRA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$30.91 M
-$13.17 M-74.21%
30 September 2024
Summary:
Zevra Therapeutics quarterly earnings before interest & taxes is currently -$30.91 million, with the most recent change of -$13.17 million (-74.21%) on 30 September 2024. Over the past year, it has dropped by -$21.09 million (-214.67%). ZVRA quarterly EBIT is now -365.76% below its all-time high of $11.63 million, reached on 01 June 2016.ZVRA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$83.75 M
-$21.09 M-33.66%
30 September 2024
Summary:
Zevra Therapeutics TTM earnings before interest & taxes is currently -$83.75 million, with the most recent change of -$21.09 million (-33.66%) on 30 September 2024. Over the past year, it has dropped by -$64.98 million (-346.12%). ZVRA TTM EBIT is now -160959.62% below its all-time high of -$52.00 thousand, reached on 01 March 2022.ZVRA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZVRA EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -68.3% | -214.7% | -346.1% |
| 3 y3 years | -681.0% | -1663.4% | -860.9% |
| 5 y5 years | +10.0% | -765.5% | -384.2% |
ZVRA EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -681.0% | at low | -565.6% | at low | <-9999.0% | at low |
| 5 y | 5 years | -681.0% | +10.0% | -565.6% | at low | <-9999.0% | at low |
| alltime | all time | -1162.3% | +11.0% | -365.8% | at low | <-9999.0% | at low |
Zevra Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$30.91 M(+74.2%) | -$83.75 M(+33.7%) |
| June 2024 | - | -$17.75 M(+11.2%) | -$62.66 M(+32.3%) |
| Mar 2024 | - | -$15.96 M(-16.6%) | -$47.37 M(+6.3%) |
| Dec 2023 | -$44.55 M(+68.3%) | -$19.14 M(+94.8%) | -$44.55 M(+137.3%) |
| Sept 2023 | - | -$9.82 M(+301.0%) | -$18.77 M(+21.3%) |
| June 2023 | - | -$2.45 M(-81.4%) | -$15.47 M(-59.0%) |
| Mar 2023 | - | -$13.14 M(-297.9%) | -$37.74 M(+42.6%) |
| Dec 2022 | -$26.47 M(+225.0%) | $6.64 M(-201.7%) | -$26.47 M(-26.0%) |
| Sept 2022 | - | -$6.53 M(-73.6%) | -$35.77 M(+15.4%) |
| June 2022 | - | -$24.72 M(+1226.9%) | -$31.00 M(>+9900.0%) |
| Mar 2022 | - | -$1.86 M(-30.1%) | -$52.00 K(-99.4%) |
| Dec 2021 | -$8.14 M(+42.8%) | - | - |
| Dec 2021 | - | -$2.66 M(+52.0%) | -$8.14 M(-6.7%) |
| Sept 2021 | - | -$1.75 M(-128.1%) | -$8.72 M(+5.5%) |
| June 2021 | - | $6.23 M(-162.6%) | -$8.27 M(-30.3%) |
| Mar 2021 | - | -$9.95 M(+206.6%) | -$11.86 M(+111.2%) |
| Dec 2020 | -$5.70 M(-68.4%) | -$3.24 M(+149.2%) | -$5.62 M(-14.3%) |
| Sept 2020 | - | -$1.30 M(-149.5%) | -$6.55 M(+981.4%) |
| June 2020 | - | $2.63 M(-171.1%) | -$606.00 K(-94.5%) |
| Mar 2020 | - | -$3.70 M(-11.5%) | -$10.96 M(-39.2%) |
| Dec 2019 | -$18.03 M | -$4.18 M(-190.0%) | -$18.03 M(+4.2%) |
| Sept 2019 | - | $4.64 M(-160.1%) | -$17.30 M(-51.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | -$7.73 M(-28.2%) | -$35.38 M(-1.4%) |
| Mar 2019 | - | -$10.77 M(+212.1%) | -$35.88 M(-27.5%) |
| Dec 2018 | -$49.51 M(+37.2%) | -$3.45 M(-74.3%) | -$49.51 M(-9.7%) |
| Sept 2018 | - | -$13.44 M(+63.4%) | -$54.82 M(+10.7%) |
| June 2018 | - | -$8.22 M(-66.3%) | -$49.53 M(+7.7%) |
| Mar 2018 | - | -$24.39 M(+178.4%) | -$45.99 M(+27.4%) |
| Dec 2017 | -$36.09 M(+283.8%) | -$8.76 M(+7.6%) | -$36.09 M(+1.9%) |
| Sept 2017 | - | -$8.15 M(+73.8%) | -$35.43 M(-8.9%) |
| June 2017 | - | -$4.69 M(-67.7%) | -$38.89 M(+72.3%) |
| Mar 2017 | - | -$14.49 M(+78.9%) | -$22.57 M(+140.0%) |
| Dec 2016 | -$9.40 M(-81.2%) | -$8.10 M(-30.1%) | -$9.40 M(+0.8%) |
| Sept 2016 | - | -$11.60 M(-199.7%) | -$9.33 M(+48.4%) |
| June 2016 | - | $11.63 M(-974.6%) | -$6.29 M(-86.5%) |
| Mar 2016 | - | -$1.33 M(-83.4%) | -$46.53 M(-7.0%) |
| Dec 2015 | -$50.06 M(+130.1%) | -$8.03 M(-6.2%) | -$50.06 M(-5.1%) |
| Sept 2015 | - | -$8.56 M(-70.1%) | -$52.73 M(+4.0%) |
| June 2015 | - | -$28.61 M(+489.0%) | -$50.70 M(+104.4%) |
| Mar 2015 | - | -$4.86 M(-54.6%) | -$24.80 M(+14.0%) |
| Dec 2014 | -$21.76 M(+516.5%) | -$10.70 M(+64.0%) | -$21.76 M(+96.8%) |
| Sept 2014 | - | -$6.53 M(+140.3%) | -$11.05 M(+144.1%) |
| June 2014 | - | -$2.71 M(+49.7%) | -$4.53 M(+149.7%) |
| Mar 2014 | - | -$1.81 M | -$1.81 M |
| Dec 2013 | -$3.53 M | - | - |
FAQ
- What is Zevra Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Zevra Therapeutics?
- What is Zevra Therapeutics annual EBIT year-on-year change?
- What is Zevra Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Zevra Therapeutics?
- What is Zevra Therapeutics quarterly EBIT year-on-year change?
- What is Zevra Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Zevra Therapeutics?
- What is Zevra Therapeutics TTM EBIT year-on-year change?
What is Zevra Therapeutics annual earnings before interest & taxes?
The current annual EBIT of ZVRA is -$44.55 M
What is the all time high annual EBIT for Zevra Therapeutics?
Zevra Therapeutics all-time high annual earnings before interest & taxes is -$3.46 M
What is Zevra Therapeutics annual EBIT year-on-year change?
Over the past year, ZVRA annual earnings before interest & taxes has changed by -$18.08 M (-68.30%)
What is Zevra Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of ZVRA is -$30.91 M
What is the all time high quarterly EBIT for Zevra Therapeutics?
Zevra Therapeutics all-time high quarterly earnings before interest & taxes is $11.63 M
What is Zevra Therapeutics quarterly EBIT year-on-year change?
Over the past year, ZVRA quarterly earnings before interest & taxes has changed by -$21.09 M (-214.67%)
What is Zevra Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of ZVRA is -$83.75 M
What is the all time high TTM EBIT for Zevra Therapeutics?
Zevra Therapeutics all-time high TTM earnings before interest & taxes is -$52.00 K
What is Zevra Therapeutics TTM EBIT year-on-year change?
Over the past year, ZVRA TTM earnings before interest & taxes has changed by -$64.98 M (-346.12%)